IRI tracks healthcare trends
This article was originally published in The Tan Sheet
Information Resources, Inc. will roll out a 34,000-plus consumer panel to track and measure consumer purchases of pharmaceuticals. RxPulse "will allow clients to monitor Rx and OTC drug usage across key segments, including ailments treated, consumer attributes and channel purchasing, for both conventional retail and online buying," IRI says June 14. Panel is first phase of what IRI terms a "suite of services for the pharmaceutical and health care markets." Market research firm also is conducting surveys to examine consumer purchase habits related to Rx, OTC drugs using InfoScan retail scanner data. IRI's announcement comes shortly after ACNielsen launched its Homescan Rx/OTC Consumer Panel, which will involve roughly 24,000 people (1"The Tan Sheet" June 3, 2002, p. 14)...
You may also be interested in...
ACNielsen's U.S. Homescan Rx/OTC Consumer Panel will help the pharmaceutical industry monitor consumers' purchasing trends with regard to new switch drugs, the market research firm contends
Caught in a ‘vaccine nationalism’ crossfire a year ago, CureVac is now well placed to become a commercial entity – just as long as its mRNA platform can deliver.
Top US FDA device center officials Jeff Shuren and William Maisel said in a 15 April blog post that manufacturers should expect a delay in the review of new product submissions thanks to the pandemic. They noted that the agency also won’t be accepting certain IVD pre-submission requests until next year.